These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 17117683)
1. Compound scale-up at the discovery-development interface. Nikitenko AA Curr Opin Drug Discov Devel; 2006 Nov; 9(6):729-40. PubMed ID: 17117683 [TBL] [Abstract][Full Text] [Related]
2. In search of sustainability: process R&D in light of current pharmaceutical industry challenges. Federsel HJ Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405 [TBL] [Abstract][Full Text] [Related]
3. [Strategy of molecular drug design: hits, leads and drug candidates]. Guo ZR Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779 [TBL] [Abstract][Full Text] [Related]
4. Precompetitive research: a new prescription for drug development? Woodcock J Clin Pharmacol Ther; 2010 May; 87(5):521-3. PubMed ID: 20407454 [No Abstract] [Full Text] [Related]
5. A decade of fragment-based drug design: strategic advances and lessons learned. Hajduk PJ; Greer J Nat Rev Drug Discov; 2007 Mar; 6(3):211-9. PubMed ID: 17290284 [TBL] [Abstract][Full Text] [Related]
6. Timely synthetic support for medicinal chemists. Potoski J Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160 [TBL] [Abstract][Full Text] [Related]
7. Strategies for bringing drug delivery tools into discovery. Kwong E; Higgins J; Templeton AC Int J Pharm; 2011 Jun; 412(1-2):1-7. PubMed ID: 21421040 [TBL] [Abstract][Full Text] [Related]
10. The role of natural product chemistry in drug discovery. Butler MS J Nat Prod; 2004 Dec; 67(12):2141-53. PubMed ID: 15620274 [TBL] [Abstract][Full Text] [Related]
11. Integrating research and development: the emergence of rational drug design in the pharmaceutical industry. Adam M Stud Hist Philos Biol Biomed Sci; 2005 Sep; 36(3):513-37. PubMed ID: 16137601 [TBL] [Abstract][Full Text] [Related]
12. Efficient and effective compound management to support lead optimization. Johnson CW; Chatterjee M; Kubala S; Helm D; Houston J; Banks M J Biomol Screen; 2009 Jun; 14(5):523-30. PubMed ID: 19483145 [TBL] [Abstract][Full Text] [Related]
13. Chemical process research and development in the 21st century: challenges, strategies, and solutions from a pharmaceutical industry perspective. Federsel HJ Acc Chem Res; 2009 May; 42(5):671-80. PubMed ID: 19338294 [TBL] [Abstract][Full Text] [Related]
14. Portfolio analysis and R&D decision making. Evans R; Hinds S; Hammock D Nat Rev Drug Discov; 2009 Mar; 8(3):189-90. PubMed ID: 19182818 [No Abstract] [Full Text] [Related]
15. Drug discovery veers off target. Shaffer C Drug Discov Today; 2005 Nov; 10(22):1489. PubMed ID: 16257367 [TBL] [Abstract][Full Text] [Related]
16. Lead optimization strategies as part of a drug metabolism environment. Korfmacher WA Curr Opin Drug Discov Devel; 2003 Jul; 6(4):481-5. PubMed ID: 12951811 [TBL] [Abstract][Full Text] [Related]
17. Aligning pharmaceutical innovation with medical need. Nathan C Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145 [No Abstract] [Full Text] [Related]
18. The Drug Discovery Portal: a resource to enhance drug discovery from academia. Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242 [TBL] [Abstract][Full Text] [Related]
19. Early chemical development at Legacy Wyeth Research. O'Brien MK; Kolb M; Connolly TJ; McWilliams JC; Sutherland K Drug Discov Today; 2011 Jan; 16(1-2):81-8. PubMed ID: 21111844 [TBL] [Abstract][Full Text] [Related]
20. Drug discovery alliances. Jones A; Clifford L Nat Rev Drug Discov; 2005 Oct; 4(10):807-8. PubMed ID: 16237845 [No Abstract] [Full Text] [Related] [Next] [New Search]